Serum IL-19 and Biglycan as Candidate Biomarkers by Proteomic Approach in Patients with Severe Low Back Pain-a Pilot Study.

Tate Q, Markova DZ, Bao J, Shofer FS, Chen K, Kepler CK, Canseco JA, Baker JF, Dillingham T, Shen L, Zhang Y

Open source

DOI
10.1097/phm.0000000000003103
Published
2026 Jul 17
Container
American journal of physical medicine & rehabilitation
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/phm.0000000000003103,
  title = {Serum IL-19 and Biglycan as Candidate Biomarkers by Proteomic Approach in Patients with Severe Low Back Pain-a Pilot Study.},
  author = {Tate Q and Markova DZ and Bao J and Shofer FS and Chen K and Kepler CK and Canseco JA and Baker JF and Dillingham T and Shen L and Zhang Y},
  year = {2026},
  journal = {American journal of physical medicine \& rehabilitation},
  doi = {10.1097/phm.0000000000003103},
  url = {https://doi.org/10.1097/phm.0000000000003103}
}

RIS

TY  - JOUR
TI  - Serum IL-19 and Biglycan as Candidate Biomarkers by Proteomic Approach in Patients with Severe Low Back Pain-a Pilot Study.
AU  - Tate Q
AU  - Markova DZ
AU  - Bao J
AU  - Shofer FS
AU  - Chen K
AU  - Kepler CK
AU  - Canseco JA
AU  - Baker JF
AU  - Dillingham T
AU  - Shen L
AU  - Zhang Y
PY  - 2026
JO  - American journal of physical medicine & rehabilitation
DO  - 10.1097/phm.0000000000003103
UR  - https://doi.org/10.1097/phm.0000000000003103
ER  - 

APA

Q, T., DZ, M., J, B., FS, S., K, C., CK, K., JA, C., JF, B., T, D., L, S., & Y, Z. (2026). Serum IL-19 and Biglycan as Candidate Biomarkers by Proteomic Approach in Patients with Severe Low Back Pain-a Pilot Study.. American journal of physical medicine & rehabilitation. https://doi.org/10.1097/phm.0000000000003103

Source records